Table 1. Baseline characteristics of the study participants.
| Variables | Frequency (%) |
|---|---|
| Demographic characteristics | |
| Age (years) | 58.74 ± 8.51 |
| Sex | |
| Female | 76 (31.4) |
| Male | 166 (68.6) |
| Clinical characteristics | |
| Frequency of Physician appointment | |
| Bi-monthly | 126 (52.1) |
| Monthly | 116 (47.9) |
| Treatments | |
| Metformin | 218 (90.1) |
| Sulphonylureas | 146 (60.3) |
| Statins | 114 (47.1) |
| Duration of T2DM (years) | 4.87 ± 4.28 |
| Anthropometry and haemodynamic characteristics | |
| Height (m) | 1.65 ± 0.08 |
| Weight (kg) | 72.72 ± 13.24 |
| BMI (kg/m2) | 26.61 ± 4.87 |
| SBP (mmHg) | 135.75 ± 15.54 |
| DBP (mmHg) | 80.89 ± 12.91 |
| Biochemical profile | |
| FBG (mmol/L) | 9.27 ±4.02 |
| HbA1c (%) | 8.87 ± 1.88 |
| TC (mmol/l) | 5.24 ± 1.58 |
| TG (mmol/L) | 1.55 ± 0.61 |
| HDL-C (mmol/L) | 1.27 ± 0.22 |
| LDL-C (mmol/L) | 3.99 ± 1.11 |
| ALT (IU/L) | 10.00 ± 8.13 |
| AST (IU/L) | 10.01 ± 7.30 |
| ALP (IU/L) | 123.05 ± 56.62 |
| Albumin (g/L) | 41.85 ± 18.30 |
| TP (g/L) | 63.54 ± 4.60 |
| Haematological profile | |
| Protein C level (μg/ml) | 5.04 (4.34–5.94) |
| Protein C activity (U/ml) | 37.33 (33.39–42.22) |
| Protein S level (μg/ml) | 20.29 (16.99–23.31) |
| Protein S activity (U/ml) | 212.58 (197.61–237.58) |
| Antithrombin III level (μg/ml) | 14.41 (11.97–17.50) |
| Antithrombin III activity (U/ml) | 160.09 (140.90–181.37) |
BMI; Body mass index, SBP; Systolic blood pressure, DBP; Diastolic blood pressure, FBG; Fasting blood glucose, HbA1c; Glycated haemoglobin, TC; Total cholesterol, TG; Triglyceride, HDL-C; High density lipoprotein cholesterol, LDL-C; Low density lipoprotein cholesterol, ALT; Alanine transaminase; AST; Aspartate transaminase, ALP; Alkaline phosphatase, TP; Total protein